CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

AbbVie releases phase 3 induction therapy data on injectable Skyrizi for Crohn's

Phase 3SkyriziNeutral
AI Analysis

Summary

AbbVie released Phase 3 induction therapy data for injectable Skyrizi in Crohn's disease. Specific efficacy and safety results are not provided in the headline.

Clinical Trial Data

Phase

3

Importance:7/10
Sentiment:
0.00
phase_3induction_therapyinjectablecrohns_disease
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on October 13, 2026 9:37 PM

Read Original